- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Dry eye disease with keratitis
- Meeting Date: March 2026
- Public Summary Document (PSD) March 2026 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2026 PBAC Meeting - (DOCX)
Ciclosporin – March 2026
Eye drops containing ciclosporin 1 mg per mL, 2 mL
Last updated
11 March 2026